ALPHAEON Corp is adding Physician Recommended Nutriceuticals (PRN) to its growing portfolio.
ALPHAEON will begin offering the omega-3 products to its approximately 1,000 physician customers participating in its customer affinity program on August 1, 2014.
ALPHAEON Corp is a subsidiary of Strathspey Crown Holdings LLC. Among other headline-making purchases, Alphaeon has acquired TouchMD, an interactive software platform. It also has the exclusive US license to market the full line of TEOXANE products and has the exclusive rights to market EVOSYAL.